3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Skin Neoplasms
1
Peritoneal Diseases
1
Ovarian Diseases
1
Neoplasms
1
Neoplasm Metastasis
1
Fallopian Tube Neoplasms
1
Fallopian Tube Diseases
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
20
Nivolumab
10
Cyclophosphamide
10
atezolizumab
6
Specimen Handling
6
fludarabine
5
Magnetic Resonance Spectroscopy
5
cabozantinib
4
Ipilimumab
4
Bevacizumab
4
lenvatinib
3
X-Rays
3
Trastuzumab
3
Paclitaxel
3
Oxaliplatin
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
ulixertinib
2
sargramostim
2
poly ICLC
2
epacadostat
2
enzalutamide
2
durvalumab
2
cemiplimab
2
budigalimab
2
avelumab
2
aldesleukin
2
aflibercept
2
Sirolimus
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tissue Banks
×
Gynecologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled